ARTICLE | Financial News
Caladrius Biosciences completes direct public offering
September 19, 2016 7:00 AM UTC
Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Business: Gene/Cell therapy, Cardiovascular, Endocrine/Metabolic Date completed: 2016-09-15 Type: Direct public offering Raised: $4 million Sha...